3 ms·
c19early.com [1] lists numerous studies for Ivermectin and other drugs in the use of treating COVID-19 for both early treatment, and throughout all stages. Ive
by rbut 5y ago
c19early.com [1] lists numerous studies for Ivermectin and other drugs in the use of treating COVID-19 for both early treatment, and throughout all stages.
Ivermectin currently sits at an average efficacy of 65% after 81 studies.
So in reality, this study that WSJ cites should be added to the pool of efficacy, and not used to completely debunk Ivermectin.
[1] https://c19early.com/ https://c19early.com/
- czowk 5y agoc19early/ivmmeta etc. and all those sites/faux meta analyses are not really reliable for determining (or even hypothesising) efficacy; We don’t see such benefit when looking at defined endpoint points in RCTs, rather than their weird synthesis of disparate cherry picked endpoints from ecological, cohort, case-control studies and RCTs. They mostly show low to very low quality/certainty evidence, as well as in vitro studies, observational studies, retrospective studies, non-randomised studies, and/or non-controlled studies. They even include studies that were negative. They also do not follow any methodological or report guidelines; i.e. not including protocol registration with methods, search strategies, inclusion criteria, quality assessment, certainly of evidence etc.
- wrycoder 5y agoAn opinion on ivermectin trials by an MD who tries to be rational: https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ https://sebastianrushworth.com/2021/05/09/update-on-ivermect...